Bristol-Myers Squibb(US:BMY) Di Yi Cai Jing·2025-10-12 10:24Group 1 - Wentech Technology's control over Anshi Semiconductor is temporarily restricted due to a ministerial order from the Dutch Ministry of Economic Affairs and Climate Policy, effective until September 30, 2025, affecting operational efficiency [3] - Baillie Gifford's subsidiary SystImmune has triggered a milestone payment of $250 million from Bristol-Myers Squibb for the izabren project, with potential additional payments of up to $7.1 billion [4] - Yunnan Copper Industry expresses uncertainty regarding the future market prices of cathode copper and gold, despite normal production operations [5] Group 2 - Zhongzhi Holdings' major shareholder, Changjiang Environmental Group, plans to transfer its entire 24.73% stake in the company, which may lead to a change in the largest shareholder [6] - Sunshine Nuohua's subsidiary has received approval for clinical trials of BTP4507, aimed at treating poorly controlled primary hypertension [7] - Mingyang Smart Energy plans to invest approximately 14.21 billion yuan to establish the UK's first integrated wind turbine manufacturing base in Scotland, pending various approvals [8] Group 3 - Tailin Microelectronics is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global development strategy [9] - Seagull Construction clarifies that it has not participated in any form of "lighthouse factory" qualification applications, despite media speculation [10] Group 4 - Hengdian East Magnetic anticipates a net profit increase of 50.1% to 65.2% for the first three quarters of 2025, projecting a profit of 1.39 billion to 1.53 billion yuan [12] - China Nuclear Power reports a cumulative power generation of 184.364 billion kWh for the first three quarters of 2025, reflecting a year-on-year growth of 14.95% [13] Group 5 - Eryuan Bio's controlling shareholder plans to reduce its stake by up to 3%, equating to a maximum of 12.1521 million shares [15] - Times New Material has signed blade sales contracts totaling approximately 4.49 billion yuan with major wind turbine manufacturers [17] - BGI Genomics' subsidiary has signed a licensing agreement for the CoolMPS sequencing technology with Swiss Rockets AG [18]